18.56
price down icon0.75%   -0.14
after-market Handel nachbörslich: 18.56
loading

Simulations Plus Inc Aktie (SLP) Neueste Nachrichten

pulisher
Dec 18, 2025

Will Simulations Plus Inc. stock maintain growth story2025 Institutional Moves & Daily Market Momentum Tracking - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

Simulations Plus (SLP) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance

Dec 18, 2025
pulisher
Dec 18, 2025

Simulations Plus to Host Virtual Investor Day Highlighting Strategy for the Next Era of Model-Informed Drug Development - 01net

Dec 18, 2025
pulisher
Dec 18, 2025

SLP Downgraded to Neutral by BTIG Analyst David Larsen | SLP Sto - GuruFocus

Dec 18, 2025
pulisher
Dec 18, 2025

Will Simulations Plus Inc. stock rally after Fed decisionsTake Profit & Weekly Watchlist for Hot Stocks - Улправда

Dec 18, 2025
pulisher
Dec 17, 2025

Simulations Plus Announces First Quarter Fiscal Year 2026 Earnings and Conference Call Date - 01net

Dec 17, 2025
pulisher
Dec 15, 2025

When Should You Buy Simulations Plus, Inc. (NASDAQ:SLP)? - Yahoo Finance

Dec 15, 2025
pulisher
Dec 14, 2025

Ranger Investment Management L.P. Trims Stake in Simulations Plus, Inc. $SLP - MarketBeat

Dec 14, 2025
pulisher
Dec 12, 2025

Simulations Plus challenges PKanalix in software efficiency - Traders Union

Dec 12, 2025
pulisher
Dec 11, 2025

Simulations Plus (NASDAQ:SLP) Updates FY 2026 Earnings Guidance - MarketBeat

Dec 11, 2025
pulisher
Dec 11, 2025

Simulations Plus Inc (NASDAQ:SLP) Nasdaq Index Fund Powers Medical Research - Kalkine Media

Dec 11, 2025
pulisher
Dec 10, 2025

Simulations Plus Positioned to Capitalize on FDA's Streamlined Nonclinical Safety Guidance with Advanced Mechanistic and Model-Informed Solutions - marketscreener.com

Dec 10, 2025
pulisher
Dec 10, 2025

Russell Investments Group Ltd. Sells 112,542 Shares of Simulations Plus, Inc. $SLP - MarketBeat

Dec 10, 2025
pulisher
Dec 09, 2025

Simulations Plus Positioned to Capitalize on FDA’s Streamlined Nonclinical Safety Guidance with Adva - pharmiweb.com

Dec 09, 2025
pulisher
Dec 09, 2025

Simulations Plus responds to FDA draft guidance on antibody testing - Investing.com

Dec 09, 2025
pulisher
Dec 09, 2025

Simulations Plus responds to FDA draft guidance on antibody testing By Investing.com - Investing.com South Africa

Dec 09, 2025
pulisher
Dec 09, 2025

Simulations Plus Positioned to Capitalize on FDA’s Streamlined Nonclinical Safety Guidance with Advanced Mechanistic and Model-Informed Solutions - The AI Journal

Dec 09, 2025
pulisher
Dec 09, 2025

Simulations Plus: Solid Platform, Soft Outlook (Rating Upgrade) - Seeking Alpha

Dec 09, 2025
pulisher
Dec 08, 2025

Simulations Plus amends executive employment agreements with new compensation terms - Investing.com

Dec 08, 2025
pulisher
Dec 06, 2025

Kennedy Capital Management LLC Sells 84,846 Shares of Simulations Plus, Inc. $SLP - MarketBeat

Dec 06, 2025
pulisher
Dec 05, 2025

Simulations Plus urges attendance for PBPK regulatory webinar - Traders Union

Dec 05, 2025
pulisher
Dec 05, 2025

How sustainable is Simulations Plus Inc. stock dividend payoutMarket Risk Analysis & Weekly High Potential Stock Alerts - Newser

Dec 05, 2025
pulisher
Dec 04, 2025

Why Shares of Simulations Plus Soared This Week - The Globe and Mail

Dec 04, 2025
pulisher
Dec 04, 2025

Simulations Plus (NASDAQ:SLP) Shareholders Are up 18% This Past Week, but Still in the Red Over the Last Five Years - 富途牛牛

Dec 04, 2025
pulisher
Dec 04, 2025

William Blair Raises Earnings Estimates for Simulations Plus - MarketBeat

Dec 04, 2025
pulisher
Dec 04, 2025

Why Simulations Plus Inc. stock could benefit from AI revolution2025 Trading Volume Trends & Fast Moving Market Watchlists - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

Simulations Plus Stock Jump Looks Great, But How Secure Is That Gain? - Trefis

Dec 03, 2025
pulisher
Dec 03, 2025

Simulations Plus' Q4 Earnings & Sales Meet Estimates, Fall Y/Y - sharewise.com

Dec 03, 2025
pulisher
Dec 02, 2025

Why Simulations Plus Stock Was Soaring Today - Finviz

Dec 02, 2025
pulisher
Dec 02, 2025

Simulations Plus: Buying On Long-Term Silico Drug-Development - Seeking Alpha

Dec 02, 2025
pulisher
Dec 02, 2025

Simulations Plus (SLP) Q3 $67M Net Loss Tests Market’s High-Growth Profitability Narrative - simplywall.st

Dec 02, 2025
pulisher
Dec 02, 2025

Insider Sell: Lisa Lavange Sells Shares of Simulations Plus Inc (SLP) - GuruFocus

Dec 02, 2025
pulisher
Dec 02, 2025

Simulations Plus (NASDAQ:SLP) Issues Quarterly Earnings Results - MarketBeat

Dec 02, 2025
pulisher
Dec 02, 2025

Simulations Plus Q4 2025 Earnings Preview - MSN

Dec 02, 2025
pulisher
Dec 02, 2025

Simulations Plus Climbs On Earnings Strength, Biotech Market ReboundSimulations Plus (NASDAQ:SLP) - Benzinga

Dec 02, 2025
pulisher
Dec 02, 2025

Simulations Plus Stock Climbs On Earnings Strength, Biotech Market Rebound - Sahm

Dec 02, 2025
pulisher
Dec 02, 2025

Simulations Plus (SLP) Poised to Benefit from New FDA Guidance - GuruFocus

Dec 02, 2025
pulisher
Dec 02, 2025

Simulations Plus Reports Q4 2025 Financial Results - MSN

Dec 02, 2025
pulisher
Dec 02, 2025

Simulations Plus Posts Strong Q4 Results, Joins Credo Technology Group, United Natural Foods, Boeing And Other Big Stocks Moving Higher On Tuesday - Benzinga

Dec 02, 2025
pulisher
Dec 02, 2025

Simulations Plus announces webinar on new GPX.2 P-PSD module - Traders Union

Dec 02, 2025
pulisher
Dec 02, 2025

Simulations Plus Q4 Revenue Slips; Reaffirms FY26 Guidance; Stock Down - Nasdaq

Dec 02, 2025
pulisher
Dec 02, 2025

Will Simulations Plus Inc. stock maintain dividend yieldIPO Watch & Risk Managed Investment Signals - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

Citizens maintains Market Perform rating on Simulations Plus stock By Investing.com - Investing.com Canada

Dec 02, 2025
pulisher
Dec 02, 2025

Simulations Plus outlines $79M–$82M FY 2026 revenue target as AI and cloud integration strategy advances - MSN

Dec 02, 2025
pulisher
Dec 02, 2025

Simulations Plus Inc (SLP) Q4 2025 Earnings Call Highlights: Navigating Market Challenges with ... By GuruFocus - Investing.com Canada

Dec 02, 2025
pulisher
Dec 02, 2025

Simulations Plus Inc (SLP) Q4 2025 Earnings Call Highlights: Nav - GuruFocus

Dec 02, 2025
pulisher
Dec 02, 2025

Simulations Plus Inc (SLP) Q4 2025 Earnings Call Highlights: Navigating Market Challenges with ... - Yahoo Finance

Dec 02, 2025
pulisher
Dec 01, 2025

Simulations Plus: Fiscal Q4 Earnings Snapshot - New Haven Register

Dec 01, 2025
pulisher
Dec 01, 2025

Simulations Plus (SLP) Reports Fiscal 2025 Growth Amid Market Ch - GuruFocus

Dec 01, 2025
pulisher
Dec 01, 2025

Simulations Plus earnings matched, revenue fell short of estimates By Investing.com - Investing.com Canada

Dec 01, 2025
$46.25
price up icon 1.00%
$28.65
price up icon 8.98%
$23.94
price up icon 0.08%
$48.05
price up icon 0.10%
health_information_services WAY
$32.58
price up icon 0.96%
$36.64
price up icon 2.98%
Kapitalisierung:     |  Volumen (24h):